Kymanox (or the “Company”) is a modern life sciences consulting company that acts as an integral extension for clients that range from emerging biotech companies to established big pharma organizations. Kymanox’s engineering, scientific, and CGxP compliance professionals provide expertise in combination products (e.g., drug/device), biologics (e.g., gene therapy), pharmaceuticals, and medical devices with support services that range from early-stage product development to post-market lifecycle management. Leveraging Kymanox’s corporate DNA of Ideal Knowledge Transfer™ (IKT™), the talented team partners with global clients to facilitate development and delivery of products with optimized safety, quality, efficacy, and accessibility. Kymanox is a global organization and the world’s first and only professional services organization that also functions as a full-fledged virtual biopharma company and created the industry’s Hyper-Virtual Model. In areas where the Company does have overlap with competitors, it is widely recognized as the world’s top professional services organization for combination products (e.g., gene therapy in a dose delivery system).
The Company was founded in 2004 with a vision to become a go-to technical and regulatory partner to life science companies and help bring products from bench to patient. Since then, Kymanox has invested significantly in its people, processes, and technology and has scaled to nearly 300 total team members today. Kymanox prides itself on continuously being at the forefront of the rapidly changing life sciences industry, providing complex and interesting projects for its employees, and differentiated services and support to its clients. Further, Kymanox is dedicated to cultivating a positive company culture that supports employees as persons, and not just workers.
Kymanox has been supported by WestView Capital Partners, a Boston-based private equity firm, since mid-2021.
Kymanox is headquartered in Research Triangle Park (RTP), North Carolina, USA and operates additional offices in King of Prussia, Pennsylvania USA, Boston, Massachusetts USA, Switzerland, and Germany.
The Chief Financial Officer role will be a key member of the Executive Leadership Team and will serve as a strategic, collaborative and business-minded partner for the business. They will provide strategic vision, leadership, mentoring, planning, oversight, and direction to Kymanox’s accounting and financial planning and analysis functions.
The CFO will continue refining a financial infrastructure that will enable faster and easier access to the current state of the business as well as measuring and reporting leading indicators. The CFO will oversee the overall accounting function including procedures, processes, structure and strategy for all financial planning and analysis, accounting functions, and senior level communication. There is presently a strong controller in place. The candidate will partner with the Executive Leadership Team to assess the financial plan and roadmaps associated with internal technologies, processes and KPIs to develop a growth stage appropriate infrastructure, and a staffing plan to support future growth.
The CFO will partner closely with the CEO and key members of management on structuring key partner contracts, pricing, new service offerings, relationships, and participate in M&A activities.
The CFO will not only have a passion for finance and accounting, but will also possess the motivation, skills, and experiences to foster a culture of collaboration between the finance and accounting teams and other functions internally within Kymanox. The candidate must lead from the front and be ready to experience the fast-paced industry and environment in which Kymanox works. The individual will also be an integral contributor to the wider strategic revenue management and development of the business.
The CFO will be responsible for managing and directing the financial and accounting functions of Kymanox in accordance with generally accepted accounting principles, all local jurisdictional authorities and other regulatory and advisory organizations, and in accordance with financial management techniques and practices appropriate within the industry.
This position is responsible for the direct supervision of the controller, FP&A Manager, and the indirect supervision of all employees in the accounting and finance department.
Responsibilities include:
Plan, develop, organize, implement, direct and evaluate the organization's finance and accounting function and performance.
Report weekly, monthly and annual financial results to both the private equity investor as well as any applicable institutional lenders. Prepare and present quarterly board meeting materials in collaboration with the rest of the Kymanox management team. As applicable, serve as primary point of contact for senior lender.
Provide timely and accurate analysis of budgets, financial reports and financial trends in order to assist the CEO, key senior executives, and the Board in performing their responsibilities.
Enhance, implement, manage, and enforce policies and procedures of the organization by way of systems that will improve the overall operation and effectiveness of the corporation.
This position requires 10% or less overnight travel.
The CFO position will come with a competitive compensation package including base salary, bonus, employee benefits and perks, and an equity incentive opportunity.
Kymanox is an equal-opportunity employer and works diligently to protect the rights of job seekers by following all local, state, and federal laws as well as best Human Resource (HR) practices in the Life Science industry.